Sanara MedTech Inc. Announces Third Quarter 2021 Results and Business Update
FORT WORTH, TX / ACCESSWIRE / November 12, 2021 / Sanara MedTech Inc.Based in Fort Worth, Texas, Sanara MedTech Inc....
Year: 2021
Zomedica Announces Third Quarter 2021 Financial Results
ANN ARBOR, MI / ACCESSWIRE / November 12, 2021 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health...
ModMed® Surpasses 100 Million Patient Encounters in Eye Care
The company continues to focus on innovating clinical workflow efficiency across the practice for providers to achieve greater ROI. NEW...
Impact Fusion International Announced today that Acra Investments Reached an Agreement in Principle with South Richmond Realty to Purchase the 62-acre Napoleonville Property
NAPOLEONVILLE, LA / ACCESSWIRE / November 12, 2021 / Impact Fusion International, Inc. (OTC PINK:IFUS):Impact Fusion International, Inc. a company...
iTolerance, Inc. to Present at Virtual Investor Roundtable Event
Live moderated video webcast discussion among members of management and Key Opinion Leaders, Andrés García, PhD, Haval Shirwan, PhD, and...
Altamira Therapeutics Reports Positive In vitro Efficacy Data for Bentrio Nasal Spray in Protecting Against Sars-CoV-2 Delta Variant
Significant reduction of infectious viral titer in human nasal epithelium model with either prophylactic or therapeutic applicationResults provide further confirmation...
Cannabis Suisse Corp. to Design a New IT Product “Cannabis Life” Based on Artificial Intelligence
DIETIKON, SWITZERLAND / ACCESSWIRE / November 12, 2021 / Cannabis Suisse Corp. (OTC PINK:CSUI), a Nevada incorporated distribution company exercising...
Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
SEATTLE, WA / ACCESSWIRE / November 12, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology...
Innovation Pharmaceuticals Conducting Full Data Analysis of Phase 2 Brilacidin COVID-19 Trial Results to Support Brilacidin’s Potential Inclusion in Government-Sponsored COVID-19 Trials
Additionally, new in vitro data also show Brilacidin targets both viral proteins and host factors, suggesting Brilacidin would be less...
IR-Med to Become Fully Reporting SEC Company
IR-Med filed an application to uplist to OTCQB New York, N.Y., Nov. 12, 2021 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK:...
BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming Conferences
BERKELEY, Calif. and VANCOUVER, British Columbia, Nov. 12, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell”...
Novan to Participate in the Virtual Investor Roundtable Event
– Live moderated video webcast discussion among management and Pediatric Dermatology Thought Leader on Wednesday, November 17th at 1:00 PM...
Sorrento Announces Publication of Significant Positive Pivotal Trial Results of Abivertinib for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in the Peer-Reviewed Journal Clinical Cancer Research
Abivertinib is a novel third-generation epidermal growth factor receptor (EGFR) inhibitor that irreversibly targets mutant forms of EGFR and Bruton’s...
InnovAge Appoints Patrick Blair as President
Patrick Blair Patrick Blair DENVER, Nov. 12, 2021 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV),...
SELLAS Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
NEW YORK, Nov. 12, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a...
Boosh Welcomes World Champion as Keynote Speaker to Planted Expo
Vancouver, British Columbia--(Newsfile Corp. - November 12, 2021) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the...
Better For You Wellness Announces Plans to Up-List to the OTCQB
Columbus, Ohio--(Newsfile Corp. - November 12, 2021) - Better For You Wellness, Inc. (OTC Pink: BFYW) ("Better For You Wellness"...
Therma Bright to Begin AcuVid(TM) U.S. Clinical Performance Study with Receipt of IRB Conditional Approval
Toronto, Ontario--(Newsfile Corp. - November 12, 2021) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer...
LENSAR Announces Poster Presentations at the American Academy of Ophthalmology
Demonstrates LENSAR Laser’s Ability to Guide Improved Astigmatic Outcomes for Patients ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the...
Relief Reports that its U.S. Collaboration Partner has Announced it has Received a U.S. Food and Drug Administration Review of Aviptadil Manufacturing Information
GENEVA, SWITZERLAND / ACCESSWIRE / November 12, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF) (" Relief "), a biopharmaceutical...